Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health. PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously – with higher sensitivity, faster throughput, and reduced turn-around time. The company’s lead product, PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to reduce the threat of COVID-19
$5M sweet spot round size
2005
$5M
from 1 investors over 1 rounds
Pictor raised $5M on January 4, 2023
Investors: Marko Bogoievski